ArticleRheumatology and therapy2018

Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland.

Rebekah H Borse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.